Journal article
Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
Abstract
The objectives were to determine the efficacy and safety of nasal salmon calcitonin 200 IU daily in the prevention of corticosteroid-induced osteoporosis. A minimized, double-blind, placebo-controlled trial was carried out in corticosteroid-treated patients with polymyalgia rheumatica. The setting was a tertiary care university-affiliated hospital and a total of 31 patients were enrolled. The primary outcome measure was the percentage change in …
Authors
Adachi JD; Bensen WG; Bell MJ; Bianchi FA; Cividino AA; Craig GL; Sturtridge WC; Sebaldt RJ; Steele M; Gordon M
Journal
Rheumatology, Vol. 36, No. 2, pp. 255–259
Publisher
Oxford University Press (OUP)
Publication Date
February 1, 1997
DOI
10.1093/rheumatology/36.2.255
ISSN
1462-0324